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NMR Structure Determination4: KTM is 
dynamic and follows predicted structure
RMS: 2.6±0.3 Å Alignment to predicted: 2.5 Å
Two major conformations of  N-terminus:
inversion of  P6? 
Lack of  defined α-helix supports CD data
Multiple dynamics observed in spectrum:
Two dominant K14 states       Alternate aromatic states/flipping
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Abstract: 
Validating Computational Results
KTM is a rationally designed alpha-conotoxin
predicted to have optimal binding affinity for the
rat α3β2 (rα3β2) nicotinic acetylcholine receptor
(nAChR) isoform,1 which has >80% sequence
homology with the human α6α4β2β3 receptor
isoform implicated in Parkinson’s Disease.2
Validation of computational accuracy will help
adjust computational parameters to give more
accurate predictions of receptor binding, which
is critical to receptor understanding and
effective drug development for
neurodegenerative diseases such as
Parkinson’s.3 The NMR structure of KTM is
currently being solved in order to validate
computational results. Current progress
indicates that the NMR structure follows the
predicted structure,4 but is not as highly
constrained as MII. Preliminary two-electrode
voltage clamp electrophysiology (TEV)
experiments confirm that KTM has affinity for
rα3β2 on the order of MII,5 supporting the
reliability of computational results.
Future Work: How does KTM move?
• MD simulations to identify peptide dynamics 
and key binding features
• Refine TEV and NMR data
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Conclusions: 
Reliable Computational Predictions 
• TEV results indicate that KTM is a high-affinity
antagonist of rα3β2
• TEV and NMR results indicate that
computational results are reliable and can be
used to predict lead compounds that will have
high binding affinity for nAChR receptor
isoforms
How was KTM designed?
KTM is based on alpha-conotoxin MII, which has
the highest binding affinity for rα3β2 known.
The computational programs GAMPMS and
Dockomatic were used to screen a peptide
mutant library for optimal binding affinity for
rα3β2.1
KTM
W C  C  S  Y P G C Y W  S  S  S  K W  C
G  C  C  S  N  P  V  C  H  L  E  H  S  N  L  C
MII
TEV Results: 
KTM is an antagonist of  rα3β2 nAChR
Preliminary TEV experiments indicate that KTM
has affinity for rα3β2 (IC50 ~3nM) on the order of
alpha-conotoxin MII (IC50 2.2nM).5
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Fig 1. Relative frequencies of amino acid 
residues present in the top 50 sequences 
obtained from GAMPMS.1
Table 1. Mutant ligand library, defined 
as a base peptide and a set of mutation 
constraints.1
